
653-47 hydrochloride
CAS No. 1224567-46-7
653-47 hydrochloride( —— )
Catalog No. M23394 CAS No. 1224567-46-7
653-47 hydrochloride is a potentiator, significantly potentiates the cAMP-response element binding protein (CREB) inhibitory activity of 666-15.?
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 177 | In Stock |
![]() ![]() |
10MG | 335 | In Stock |
![]() ![]() |
25MG | 566 | In Stock |
![]() ![]() |
50MG | 806 | In Stock |
![]() ![]() |
100MG | 1098 | In Stock |
![]() ![]() |
500MG | 2205 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product Name653-47 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief Description653-47 hydrochloride is a potentiator, significantly potentiates the cAMP-response element binding protein (CREB) inhibitory activity of 666-15.?
-
Description653-47 hydrochloride is a potentiator, significantly potentiates the cAMP-response element binding protein (CREB) inhibitory activity of 666-15.?It is also a very weak CREB inhibitor with IC50 of 26.3 μM.
-
In Vitro653-47 (5-10 μM) synergistically inhibits CREB-mediated gene transcription with 666-15.
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorCREB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1224567-46-7
-
Formula Weight407.29
-
Molecular FormulaC20H20Cl2N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:250 mg/mL?(613.81 mM;?Need ultrasonic)
-
SMILESO=C(NC1=CC=C(C=C1O)Cl)C2=C(C=C3C=CC=CC3=C2)OCCCN.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Xie F, et al. Discovery of a Synergistic Inhibitor of cAMP-Response Element Binding Protein (CREB)-Mediated Gene Transcription with 666-15. J Med Chem. 2019;62(24):11423-11429.
molnova catalog



related products
-
Tz-Thalidomide
Tz-Thalidomide is a tetrazine-modified Thalidomide (E3 ligase ligand) with some affinity for BRD4.
-
MS645
MS645 is an inhibitor of bromodomain-containing protein 4 (BRD4) with a Ki of 18.4 nM for BRD4-BD1/BD2.
-
Trotabresib
Trotabresib (CC-90010) is an orally active inhibitor of BET and can be used in studies about advanced solid tumors.